Hypermarcas Acquires OTC Drugmaker Luper

Brazilian multi-brand consumer goods-maker Hypermarcas has again increased its exposure to the pharmaceutical sector, announcing the signing of a memorandum of understanding to acquire over-the-counter (OTC) medicine manufacturer Luper Pharmaceutical Industry for BRL52.1mn (US$29.5mn). Hypermarcas states the acquisition complements its portfolio of branded generics and OTC products. BMI believes the deal should prove profitable for Hypermarcas, despite its relatively low value, building on the company's acquisition of Neo Quimica in late

To read the full article, please choose one of the following options: